# FcR Therapeutics

Private

**Utrecht**  
**Healthcare & Life Sciences**  
[Website](https://www.fcrtherapeutics.com/)

**Last Round**: Seed  
**Date**: Feb 4, 2025

## Company Overview

FcR Therapeutics is a biotechnology company that develops recombinant nanobody-based therapeutics to modulate Fc receptor activity for the treatment of autoimmune diseases.

- **Sector**: Healthcare & Life Sciences
- **Verticals**: Biotechnology, Drug Discovery
- **Business Model**: B2B
- **Customer Profile**: Services & Consulting
- **AI Layer**: Non-AI

**Keywords**: nanobody therapeutics, recombinant nanobodies, autoimmune disease treatment, biotech drug discovery, Fc receptor modulation, biologics, immunology, drug development pipeline, biopharmaceutical R&D, therapeutic proteins, next-gen biologics, autoimmune research, single domain antibodies

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

### Unlock Pricing Charts

## Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

### View Momentum History

## FcR Therapeutics Comparables

Compare FcR Therapeutics with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [Kaigene Inc.](/content/company/kaigene/index.html) | 79% | Unlock |
| [Nuvig Therapeutics](/content/company/nuvig-therapeutics/index.html) | 78% | Unlock |
| [Cerberus Therapeutics](/content/company/cerberustx/index.html) | 77% | Unlock |
| Comparable company | 50% | Unlock |

## FcR Therapeutics Funding Rounds

Historical fundraising activity.

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Seed | Feb 4, 2025 | Unlock | Unlock | Unlock | Unlock |

## Key People

Founding team and executive leadership.

- **Geert van Tetering**  
  Chief Scientific Officer, Founder & Chief Operating Officer  
  [LinkedIn profile](https://www.linkedin.com/in/geertvantetering "LinkedIn profile")
- **Guido Maertens**  
  CEO and co-founder FcR Therapeutics  
  [LinkedIn profile](https://www.linkedin.com/in/guidomaertens "LinkedIn profile")

## Market signals

Structured signals derived from secondary market and firmographic data.

- Mar 3, 2026  
  Monthly visitors increased 168% MoM, reaching 260.

## FcR Therapeutics Filings

SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

Common questions about FcR Therapeutics's valuation, stock price, and market status.

- Is FcR Therapeutics a public or private company?
- What is the current stock price of FcR Therapeutics?
- How much is FcR Therapeutics worth (valuation)?
- Can I buy FcR Therapeutics stock?
- When was FcR Therapeutics's last funding round?
- Who are the main investors in FcR Therapeutics?
- Will FcR Therapeutics IPO soon?
- How can I track FcR Therapeutics secondary market activity?

## Firmographic Details

- **Headquarters**: Utrecht  
- **Employee Range**: 4  
- **Year Founded**: 2025  
- **Last Funding**: Feb 4, 2025